{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T15:40:35Z","timestamp":1774280435984,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ctim.2014.08.003","type":"journal-article","created":{"date-parts":[[2014,8,18]],"date-time":"2014-08-18T02:00:50Z","timestamp":1408327250000},"page":"877-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The clinical absolute and relative scoring system\u2014A quantitative scale measuring myasthenia gravis severity and outcome used in the traditional Chinese medicine"],"prefix":"10.1016","volume":"22","author":[{"given":"Guo-Chao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-0737","authenticated-orcid":false,"given":"Bu-Lang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Yan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2014.08.003_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.21713","article-title":"History of outcome measures for myasthenia gravis","volume":"42","author":"Burns","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ctim.2014.08.003_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1477-7525-8-129","article-title":"Quality of life and life circumstances in German myasthenia gravis patients","volume":"8","author":"Twork","year":"2010","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ctim.2014.08.003_bib0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0020","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1212\/WNL.40.12.1828","article-title":"Indications for thymectomy in myasthenia gravis","volume":"40","author":"Lanska","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1055\/s-2008-1041066","article-title":"Myasthenia gravis: pathogenesis and treatment","volume":"14","author":"Richman","year":"1994","journal-title":"Semin Neurol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0733-8619(18)30101-4","article-title":"The treatment of patients with myasthenia gravis","volume":"12","author":"Sanders","year":"1994","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ctim.2014.08.003_bib0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.autrev.2007.01.001","article-title":"Therapeutic options in autoimmune myasthenia gravis","volume":"6","author":"Garcia-Carrasco","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ctim.2014.08.003_bib0040","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/acm.2009.0101","article-title":"Therapeutic history of Parkinson's disease in Chinese medical treaties","volume":"11","author":"Zheng","year":"2009","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.ctim.2014.08.003_bib0045","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.tips.2005.09.006","article-title":"Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science","volume":"26","author":"Jiang","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ctim.2014.08.003_bib0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s12016-012-8332-0","article-title":"Traditional Chinese medicine and immune regulation","volume":"44","author":"Ma","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1749-8546-7-16","article-title":"Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang","volume":"7","author":"Wang","year":"2012","journal-title":"Chin Med"},{"key":"10.1016\/j.ctim.2014.08.003_bib0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jep.2009.05.013","article-title":"Beneficial effect of bupleurum polysaccharides on autoimmune disease induced by campylobacter jejuni in BALB\/c mice","volume":"124","author":"Wang","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0065","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0306-3623(96)00084-5","article-title":"Immunomodulatory effect of a polysaccharide-enriched preparation of codonopsis pilosula roots","volume":"27","author":"Wang","year":"1996","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jep.2007.05.030","article-title":"Huperzine a from huperzia species\u2014an ethnopharmacolgical review","volume":"113","author":"Ma","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0075","first-page":"300","article-title":"Regulatory action of Astragalus saponins and buzhong yiqi compound on synthesis of nicotinic acetylcholine receptor antibody in vitro for myasthenia gravis","volume":"107","author":"Tu","year":"1994","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ctim.2014.08.003_bib0080","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3736\/jcim20080918","article-title":"Integrated traditional Chinese and Western medicine in treating 31 cases of myasthenia gravis","volume":"6","author":"Chen","year":"2008","journal-title":"Zhong Xi Yi Jie He Xue Bao = J Chin Integr Med"},{"key":"10.1016\/j.ctim.2014.08.003_bib0085","first-page":"271","article-title":"Clinical study of strengthening pi and nourishing shen therapy combined with western medicine on patients with glucocorticoid resistant myasthenia gravis","volume":"30","author":"Liu","year":"2010","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chin J Integr Tradit West Med\/Zhongguo Zhong Xi Yi Jie He Xue Hui, Zhongguo Zhong Yi Yan Jiu Yuan Zhu Ban"},{"key":"10.1016\/j.ctim.2014.08.003_bib0090","first-page":"177","article-title":"Clinical efficacy of Yiqi Qushi Recipe in treating myasthenia gravis and observation of its immunomodulatory effects","volume":"33","author":"Xu","year":"2013","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chin J Integr Tradit West Med\/Zhongguo Zhong Xi Yi Jie He Xue Hui, Zhongguo Zhong Yi Yan Jiu Yuan Zhu Ban"},{"key":"10.1016\/j.ctim.2014.08.003_bib0095","first-page":"87","article-title":"A clinical absolute and relative sore system for myasthenia gravis","volume":"30","author":"Wang","year":"1997","journal-title":"Zhonghua Shen Jing Ke Za Zhi"},{"key":"10.1016\/j.ctim.2014.08.003_bib0100","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1196\/annals.1254.056","article-title":"Standards of measurements in myasthenia gravis","volume":"998","author":"Barohn","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctim.2014.08.003_bib0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctim.2014.08.003_bib0110","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/mus.21053","article-title":"Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ctim.2014.08.003_bib0115","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ctim.2014.08.003_bib0120","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM198209233071301","article-title":"Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis","volume":"307","author":"Drachman","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctim.2014.08.003_bib0125","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in musk antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ctim.2014.08.003_bib0130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1196\/annals.1254.058","article-title":"Standards of measurements in myasthenia gravis","volume":"998","author":"Gajdos","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctim.2014.08.003_bib0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the myasthenia gravis foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00314245","article-title":"Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis","volume":"235","author":"Mantegazza","year":"1988","journal-title":"J Neurol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0145","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21016","article-title":"Disease-specific measure of quality of life for myasthenia gravis","volume":"38","author":"Mullins","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ctim.2014.08.003_bib0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s100720200027","article-title":"Myasthenia gravis outcome measure: development and validation of a disease-specific self-administered questionnaire","volume":"23","author":"Padua","year":"2002","journal-title":"Neurol Sci: Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0155","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0160","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1196\/annals.1254.057","article-title":"A simple manual muscle test for myasthenia gravis: validation and comparison with the QMG score","volume":"998","author":"Sanders","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctim.2014.08.003_bib0165","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s004150050585","article-title":"Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis","volume":"247","author":"Sharshar","year":"2000","journal-title":"J Neurol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0170","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0175","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/mus.23330","article-title":"Recommendations for myasthenia gravis clinical trials","volume":"45","author":"Benatar","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ctim.2014.08.003_bib0180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archinte.1958.00260190074008","article-title":"Studies in myasthenia gravis; review of two hundred eighty-two cases at the Mount Sinai Hospital, New York City","volume":"102","author":"Osserman","year":"1958","journal-title":"A.M.A. Arch Intern Med"},{"key":"10.1016\/j.ctim.2014.08.003_bib0185","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0022-510X(64)90171-6","article-title":"Studies in myasthenia gravis. 1. A clinical study of 180 patients","volume":"38","author":"Oosterhuis","year":"1964","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ctim.2014.08.003_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0303-8467(81)90014-7","article-title":"Myasthenia gravis. A survey","volume":"83","author":"Oosterhuis","year":"1981","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ctim.2014.08.003_bib0195","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.410150316","article-title":"Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients","volume":"15","author":"Pascuzzi","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00315656","article-title":"A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy","volume":"237","author":"Mantegazza","year":"1990","journal-title":"J Neurol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0205","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"Besinger","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0210","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410170304","article-title":"Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine","volume":"17","author":"Hohlfeld","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0215","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1749-6632.1993.tb22937.x","article-title":"A clinical therapeutic trial of cyclosporine in myasthenia gravis","volume":"681","author":"Tindall","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctim.2014.08.003_bib0220","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"Tindall","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctim.2014.08.003_bib0225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1196\/annals.1405.001","article-title":"Treatment of myasthenia gravis acute exacerbations with intravenous immunoglobulin","volume":"1132","author":"Gajdos","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctim.2014.08.003_bib0230","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Clinical Study Group","volume":"41","author":"Gajdos","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ctim.2014.08.003_bib0235","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/mus.21142","article-title":"Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis","volume":"38","author":"Wolfe","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ctim.2014.08.003_bib0240","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/01.wnl.0000312373.67493.7f","article-title":"A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis","volume":"71","author":"Muscle Study Group","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0245","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/01.WNL.0000163988.28892.79","article-title":"Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity","volume":"64","author":"Bedlack","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0250","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181dc1b1e","article-title":"The mg composite: a valid and reliable outcome measure for myasthenia gravis","volume":"74","author":"Burns","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0255","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0260","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1196\/annals.1405.038","article-title":"IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies","volume":"1132","author":"Zinman","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ctim.2014.08.003_bib0265","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.56.1.94","article-title":"Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases","volume":"56","author":"Chaudhry","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ctim.2014.08.003_bib0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jnnp.2005.072355","article-title":"Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001","volume":"77","author":"Owe","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229914001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229914001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:02:34Z","timestamp":1760806954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229914001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0965229914001319"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2014.08.003","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical absolute and relative scoring system\u2014A quantitative scale measuring myasthenia gravis severity and outcome used in the traditional Chinese medicine","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2014.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}